The trial also has several limitations: (1) As GPs in the Czech Republic only follow prediabetes and uncomplicated type 2 diabetes patients not taking insulin, the findings of the trial cannot be generalised to insulin-dependent diabetes patients or those with high HbA1c levels. Here, INS is linked to type 2 diabetes mellitus.